510(k) Report

510(k) · Cleared

Cleared

Navigus II MR

K012719510(k) TraditionalCleared Oct 22, 200169-day reviewClass II21 CFR 882.4560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Image-Guided Neurologics, Inc. · HAW Neurological Stereotaxic Instrument

Cleared on Oct 22, 2001 after a 69-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 13 later devices descend from it.

Decided
Oct 22, 2001
Review
69 days
Class
Class II
Product code
HAW
Recalls
None
Predicates
0

13 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2011: 1 descendant cleared2015: 1 descendant cleared2016: 1 descendant cleared2017: 1 descendant cleared2018: 1 descendant cleared2022: 2 descendants cleared2020: 1 descendant cleared2021: 1 descendant cleared2023: 2 descendants cleared2025: 1 descendant cleared200020052010201520202025
  1. This deviceK012719 Navigus II MRImage-Guided Neurologics, Inc. · 2001
  2. Descendant · cites it directly · 12 of its ownK100836 Clearpoint SystemSurgivision, Inc. · 2010
  3. Descendant · 2 generations on · 11 of its ownK111073 Surgivision Inc. Clearpoint SystemSurgi-Vision, Inc. · 2011
  4. Descendant · 3 generations on · 10 of its ownK142505 ClearPoint SystemMri Interventions, Inc. · 2015
  5. Descendant · 4 generations on · 9 of its ownK160434 ClearPoint SystemMri Interventions, Inc. · 2016
  6. Descendant · 5 generations on · 8 of its ownK171257 ClearPoint SystemMri Interventions, Inc. · 2017

Showing 5 of 13 descendants. See all descendants

Descendants cleared per year

2010: 12011: 12015: 12016: 12017: 12018: 12020: 12021: 12022: 22023: 22025: 1
2010high 2 (2022) · low 0 (2012)2026

Most influential descendants

Showing 5 of 13 · See all
  • K100836Clearpoint SystemSurgivision, Inc. · 2010 · cites it directly12descendants
  • K111073Surgivision Inc. Clearpoint SystemSurgi-Vision, Inc. · 2011 · 2 generations on11descendants
  • K142505ClearPoint SystemMri Interventions, Inc. · 2015 · 3 generations on10descendants
  • K160434ClearPoint SystemMri Interventions, Inc. · 2016 · 4 generations on9descendants
  • K171257ClearPoint SystemMri Interventions, Inc. · 2017 · 5 generations on8descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K012719Navigus II MRImage-Guided Neurologics, Inc.2001—
+1K100836Clearpoint SystemSurgivision, Inc.2010—
+2K111073Surgivision Inc. Clearpoint SystemSurgi-Vision, Inc.2011—
+3K142505ClearPoint SystemMri Interventions, Inc.2015—
+4K160434ClearPoint SystemMri Interventions, Inc.2016—
+5K171257ClearPoint SystemMri Interventions, Inc.2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201110
201510
201610
201710
201810
202010
202110
202220
202320
202510
FIG. 1 — Lineage of K012719, 2001–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HAW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HAW device

  1. #1 K253856 Geniant Cranial (Navigated Neurosurgical…score 15.0 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (13)

See all 13

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K100836Clearpoint SystemSurgivision, Inc.201012

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K100836 (Surgivision, Inc., 2010) has gone furthest, with 12 descendants of its own.

How does its category compare?

All HAW devices

HAW Neurological Stereotaxic Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HAW

9in 2025

2007: 152008: 122009: 82010: 62011: 42012: 82013: 32014: 52015: 102016: 92017: 72018: 62019: 102020: 52021: 92022: 72023: 142024: 72025: 92026 (partial year): 5
2007high 15 (2007) · low 3 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HAW

163in 2025

2007: 107 days median2008: 112 days median2009: 221 days median2010: 138 days median2011: 66 days median2012: 178 days median2013: 172 days median2014: 238 days median2015: 232 days median2016: 175 days median2017: 226 days median2018: 112 days median2019: 147 days median2020: 88 days median2021: 168 days median2022: 128 days median2023: 142 days median2024: 107 days median2025: 163 days median2026 (partial year): 162 days median
2007high 238 (2014) · low 66 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HAW

2in 2025

2007: 22008: 102009: 62010: 282011: 52012: 42013: 6, 1 Class I2014: 52015: 32016: 52017: 22018: 2, 2 Class I2019: 4, 1 Class I2020: 12021: 4, 2 Class I2022: 12023: 4, 1 Class I2024: 2, 2 Class I2025: 22026 (partial year): 6
2007high 28 (2010) · low 1 (2020)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · HAW

3,425in 2025

2007: 492008: 532009: 962010: 2992011: 1,7252012: 9862013: 1,2902014: 1,6062015: 1,7672016: 1,8282017: 3,5052018: 4,4392019: 6,0622020: 3,4802021: 2,8272022: 1,9292023: 2,5102024: 3,7552025: 3,425
2007high 6,062 (2019) · low 49 (2007)2025

MAUDE reports naming product code HAW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200715107249
2008121121053
20098221696
2010613828299
201146651,725
201281784986
201331726 (1)1,290
2014523851,606
20151023231,767
2016917551,828
2017722623,505
201861122 (2)4,439
2019101474 (1)6,062
202058813,480
202191684 (2)2,827
2022712811,929
2023141424 (1)2,510
202471072 (2)3,755
2025916323,425
202651626—

What is it indicated for?

Intended Use: The NAVIGUS II MR Trajectory Guide is intended to provide stereotactic guidance for the placement and operation of instruments or devices during planning and operation of neurological procedures within the MRI environment and in conjunction with MR imaging. The Trajectory Guide is intended as an integral part of procedures that have traditionally used stereotactic methodology. These procedures include biopsies, catheter and electrode introduction.

This device will provide accurate delivery of devices or instruments to target sites 3mm and larger.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012719: Navigus II MR.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K012719

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026